Novavax Announces Memorandum of Understanding with Gavi for Cumulative Supply to COVAX Facility of 1.1 Billion Doses of COVID-19 Vaccine

    NEXT STORY
    Ascendis Pharma A/S Announces Participation at SVB Leerink 10th Annual Global Healthcare Conference
    PREV STORY
    Adverum Appoints Christopher J. DeRespino as Chief Business Officer
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Dynavax’s SD-101 and 4SC’s Domatinostat Demonstrate Synergy and Induce a Systemic Anti-tumor Response in Preclinical Models

    author_avatar
    NASDAQ Market News

    Five Prime Announces Fourth Quarter and Full Year 2016 Financial Results

    SOUTH SAN FRANCISCO, Calif., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. ...

    author_avatar
    NASDAQ Market News

    SELLAS Announces Promising Initial Clinical Data for Galinpepimut-S (GPS) in Combination with Checkpoint Inhibitors in Two Solid Tumor Indications

    author_avatar
    NASDAQ Market News